• FOLLOW US
Video Player
  • Email
  • share

Dicerna CEO: Our Technology is Superior, Eyes FDA Approval

Dicerna aims to treat diseases that have never been treated before. Dicerna CEO, Dr. Douglas Fambrough, explains this is an emerging class of biotech and his company's technology is superior to its peers because the company has used an optimized form

http://www.wusa9.com/video/3678442590001/1/Dicerna-CEO-Our-Technology-is-Superior-Eyes-FDA-Approval http://cdn.newslook.com/79/79ac66eec7b6108f6c8774b4ae3368b4/images/frame_ext.jpg Dicerna CEO: Our Technology is Superior, Eyes FDA Approval Dicerna aims to treat diseases that have never been treated before. Dicerna CEO, Dr. Douglas Fambrough, explains this is an emerging class of biotech and his company's technology is superior to its peers because the company has used an optimized form FinanceyoutubeYahoo!newslook 02:12

Next Up

    

More Videos